Lisdexamfetamine 30 MG capsule 100S
Ended Awarded
- Contract number
- SPE2DR26F0VZ5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,080
Award facts
- Contract value 100% obligated
- $1,079.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Lisdexamfetamine 30 mg capsules (100 count) with a ceiling value of $1,079.80. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 31, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems. The company's DLA prime contract enables delivery of a broad portfolio of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, and medical commodities across multiple therapeutic domains. The current delivery order for Lisdexamfetamine—a controlled medication used to treat attention deficit hyperactivity disorder—represents one of numerous pharmaceutical supply orders the company fulfills under its DLA contract vehicle to support Defense Health Agency and other federal healthcare customers.
Quick answers
Who was awarded contract SPE2DR26F0VZ5?
SPE2DR26F0VZ5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 30, 2025.
How much is contract SPE2DR26F0VZ5 worth?
The government has obligated $1,080 on SPE2DR26F0VZ5.
Is contract SPE2DR26F0VZ5 an order under another contract?
Yes. SPE2DR26F0VZ5 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F0VZ5 competed?
The extent of competition for SPE2DR26F0VZ5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award